Samsung Biologics to Showcase Global Expansion and Strategic Initiatives at DCAT Week 2026

Samsung Biologics is showcasing its global expansion and strategic initiatives at DCAT Week 2026 in New York City. The company's Executive Vice President and Head of Sales and Operations, Kevin Sharp, presented updates on capacity and geographical expansion, highlighting ongoing investments and key collaborations, including a partnership with CEPI and an open innovation center with Eli Lilly. Throughout the week, Samsung Biologics' leadership will engage with clients to discuss manufacturing and development capabilities.